These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25652732)

  • 1. Formulation of Eco-friendly Medicated Chewing Gum to Prevent Motion Sickness.
    Shete RB; Muniswamy VJ; Pandit AP; Khandelwal KR
    AAPS PharmSciTech; 2015 Oct; 16(5):1041-50. PubMed ID: 25652732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-optimal mixture design: Formulation development, mechanical characterization, and optimization of curcumin chewing gums using oppanol® B 12 elastomer as a gum-base.
    Al Hagbani T; Altomare C; Salawi A; Nazzal S
    Int J Pharm; 2018 Dec; 553(1-2):210-219. PubMed ID: 30347275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of medicated chewing gum of taste masked levocetirizine dihydrochloride using different gum bases:
    Marzouk MA; Darwish MK; Abd El-Fattah MA
    Drug Dev Ind Pharm; 2020 Mar; 46(3):395-402. PubMed ID: 31996053
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicated Chewing Gums (MCGs): Composition, Production, and Mechanical Testing.
    Al Hagbani T; Nazzal S
    AAPS PharmSciTech; 2018 Oct; 19(7):2908-2920. PubMed ID: 30088152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, formulation, and evaluation of ginger medicated chewing gum.
    Aslani A; Ghannadi A; Rostami F
    Adv Biomed Res; 2016; 5():130. PubMed ID: 27563640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of dye as tracer of drug release from medicated chewing gums.
    Ochoa E; Maggi L; Conti S; Conte U; Vergnault G; Grenier P
    Eur J Pharm Biopharm; 2008 Mar; 68(3):811-7. PubMed ID: 17951037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating release kinetics of phenolics from defatted wheat germ incorporated chewing gums.
    Özdoğan A; Gunes R; Palabiyik I
    J Sci Food Agric; 2019 Nov; 99(14):6333-6341. PubMed ID: 31268169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of postcompressional textural tests to evaluate the mechanical properties of medicated chewing gum tablets with high drug loadings.
    Al Hagbani T; Nazzal S
    J Texture Stud; 2018 Feb; 49(1):30-37. PubMed ID: 28776678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device.
    Maggi L; Segale L; Conti S; Ochoa Machiste E; Salini A; Conte U
    Eur J Pharm Sci; 2005 Apr; 24(5):487-93. PubMed ID: 15784338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the compressibility of chewing gum and its applicability as an oral drug delivery system.
    Jójárt I; Kása P; Kelemen A; Pintye-Hódi K
    Pharm Dev Technol; 2016; 21(3):321-7. PubMed ID: 25673279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system.
    Faraj JA; Dorati R; Schoubben A; Worthen D; Selmin F; Capan Y; Leung K; DeLuca PP
    AAPS PharmSciTech; 2007 Mar; 8(1):26. PubMed ID: 17408225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic flavor release from chewing gum: Mechanisms of release.
    Hinderink EBA; Avison S; Boom R; Bodnár I
    Food Res Int; 2019 Feb; 116():717-723. PubMed ID: 30717000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chewing gum and lozenges as delivery systems for noscapine.
    Jensen LN; Christrup LL; Menger N; Bundgaard H
    Acta Pharm Nord; 1991; 3(4):219-22. PubMed ID: 1781914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development of medicated chewing gum tablets by direct compression using the SeDeM-Diagram-Expert-System.
    Zieschang L; Klein M; Jung N; Krämer J; Windbergs M
    Eur J Pharm Biopharm; 2019 Nov; 144():68-78. PubMed ID: 31493511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo predictive release methods for medicated chewing gums.
    Gajendran J; Kraemer J; Langguth P
    Biopharm Drug Dispos; 2012 Oct; 33(7):417-24. PubMed ID: 22674680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chewing gum reduces visually induced motion sickness.
    Kaufeld M; De Coninck K; Schmidt J; Hecht H
    Exp Brain Res; 2022 Feb; 240(2):651-663. PubMed ID: 34997261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation.
    Seibel K; Schaffler K; Reitmeir P; Golly I
    Arzneimittelforschung; 2002; 52(7):529-36. PubMed ID: 12189776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equipment for drug release testing of medicated chewing gums.
    Kvist LC; Andersson SB; Berglund J; Wennergren B; Fors SM
    J Pharm Biomed Anal; 2000 Apr; 22(3):405-11. PubMed ID: 10766358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raman Imaging as a powerful tool to elucidate chemical processes in a matrix: Medicated chewing gums with nicotine.
    Poulsen J; Nielsen KA; Bauer-Brandl A
    J Pharm Biomed Anal; 2022 Feb; 209():114519. PubMed ID: 34906922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of Medicated Chewing Gum Containing Sceletium tortuosum and Process Optimization Utilizing the SeDeM Diagram Expert System.
    Viljoen JM; van der Walt S; Hamman JH
    AAPS PharmSciTech; 2021 Mar; 22(3):102. PubMed ID: 33712901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.